RE:alleyes....JAZZ paid $7.2B for GW pharma....BAD move by JAZZYou must keep in mind the only way to sell CBD on a pharmaceutical/prescription basis PRESENTLY is to pursue a generic offering of epidiolex specifically due to the referencing of clinical trials or "piggy backing" off the original developers successful, FDA reviewed clinical trials....of course there are more trials and CAPI's..(cannabinoid active pharmaceutical ingredients)...going through trials Thom which labs is the sponsor, however it appears this is the "Low hanging fruit" from my perspective and the commentary/actions/and achievements all point to this being the first actual pharmaceutical drug offering from the Corp and what's got me jazzed is the fact this MAJOR event is NEAR and NOBODY seems to be aware what's actually happening....this is not speculation......they literally are one patent challenge away....no other Corp is anywhere near the point of being able to submit such challenge.....if successful LABS literally labels it's CBD 100 formulation and ships for 10..15...X the current price...ED you continue to bring strong valid intriguing points to light and I sincerely thank you for your insight.